SEMAGLUTIDE & TIRZEPATIDE · MILLBURN, NJ

Semaglutide is an FDA-approved medication that belongs to a class of drugs called GLP-1 receptor agonists. It works by mimicking a hormone that targets areas of the brain involved in appetite regulation, helping you feel fuller longer and reducing hunger. Originally developed for treating type 2 diabetes, it has shown remarkable effectiveness for weight management.

Semaglutide works in multiple ways to support weight loss:

• Slows stomach emptying, helping you feel full longer after eating
• Reduces appetite and hunger signals in the brain
• Decreases food cravings, particularly for high-fat foods
• Helps regulate blood sugar levels
• Supports feeling satisfied with smaller portions

Clinical studies have shown that people taking Semaglutide, combined with lifestyle modifications, typically lose 15-20% of their body weight over 68 weeks. Individual results vary based on starting weight, adherence to dietary and exercise recommendations, and other health factors. Dr. Menon will help set realistic expectations based on your specific situation.

Semaglutide is administered as a once-weekly subcutaneous injection. At Menon Medispa, Dr. Aditi Menon will provide comprehensive training on self-administration or can administer the injection for you during office visits. The medication is typically started at a lower dose and gradually increased to minimize side effects.

Yes. Menon Medispa offers physician-directed Semaglutide weight loss support from our Millburn, NJ office. The program is designed for appropriate candidates and includes medical review, monitoring, and lifestyle guidance.

Common side effects of Semaglutide may include:

• Nausea (most common, especially when starting treatment)
• Diarrhea
• Vomiting
• Constipation
• Abdominal pain
• Headache

Most side effects are mild to moderate and tend to decrease over time. Dr. Menon employs a gradual dose escalation strategy to minimize these effects and will work with you to manage any discomfort.

Semaglutide and Tirzepatide are intended for adults working toward meaningful, medically supervised weight loss, and Dr. Menon reviews your full medical history to confirm they are appropriate for you. They are generally not recommended during pregnancy or breastfeeding, or for people with a personal or family history of medullary thyroid carcinoma or MEN 2 (multiple endocrine neoplasia type 2). Your consultation and medical review determine whether the program is the right fit.

Our physician-directed Semaglutide program starts at $100. Your exact cost depends on your dose and the length of your plan, which Dr. Menon confirms at your consultation. The program includes medical review, monitoring, and lifestyle guidance.

Tirzepatide is priced per injection by dose: 2.5 mg is $150, 5 mg is $175, 7.5 mg is $200, and 10 mg is $225. Dr. Menon will recommend the right starting dose at your consultation and adjust it over time based on your response.

Both are once-weekly injections that reduce appetite and support weight loss. Tirzepatide activates two gut-hormone pathways (GIP and GLP-1) while Semaglutide activates one (GLP-1), and in studies Tirzepatide has produced greater average weight loss for many patients. The best choice depends on your health history, goals, budget, and how you respond, and Dr. Menon will help you decide.